Profile ready
Bio · photo · LinkedIn
Profile complete: bio, photo and LinkedIn URL added.
About
Across 25+ years in healthcare technology and SaaS, I have led multiple organizations through growth, turnaround, and transformation—returning declining businesses to year-over-year expansion, driving ARR growth in new segments, and integrating acquisitions into a single, coherent revenue engine. I have built and led high-performance commercial teams, doubled channel and partnership revenue, and taken companies into new markets such as US home health and international regions while also shifting models from perpetual license to SaaS.
As an advisor or board member, I bring a pattern-recognition lens on what it takes to build a repeatable go-to-market engine: clear segmentation and positioning, disciplined pipeline management, effective channel and OEM partnerships, and data-driven decision making across sales and marketing. I am especially valuable when a company needs to re-architect GTM, align product and sales, or restore growth while protecting profitability and capital efficiency.
What makes me a strong advisor/board member?
Proven turnaround and restructuring capability: I have returned Interlace Health to growth after consecutive down years, revitalized Strata Health’s US performance, and driven 40%+ growth in prior turnaround roles.
Deep GTM and channel expertise in health tech: I have launched and scaled cloud platforms, built indirect and OEM channels (e.g., Meditech, IBM, Canon), and secured industry-defining partnerships with major EHR and health IT players like Cerner, Allscripts, GE, and McKesson.
Large- and mid-market perspective: I have managed a $250M+ revenue business with a 150-person team at Nuance while also building ARR from zero to multi-million levels in early-stage ventures such as NoteSwift.
Governance, ecosystem and stakeholder savvy: My leadership in CHIME, HIMSS, and MEDITECH’s user community, plus your experience in large capital campaigns, demonstrates comfort with stakeholder management, governance-style decision making, and healthcare policy and provider dynamics.
Companies that benefit most from your expertise
The companies that will get the most leverage from me are:
Growth-stage health tech and SaaS companies (roughly $5M–$75M ARR) selling into health systems, physician groups, payers, or post-acute that need to clarify GTM, strengthen pipeline, and professionalize sales/marketing operations.
Turnaround or stalled-growth HCIT firms that have solid products and customers but inconsistent execution, where your experience returning businesses to growth and restructuring commercial functions can materially shift the trajectory.
Product-led or founder-led startups entering enterprise healthcare for the first time, where they need guidance on enterprise sales motion, partner strategy, and navigating complex players like EHR vendors, IDNs, and channel partners.
Companies integrating acquisitions or expanding internationally, where your history integrating four sales organizations at Nuance and leading UK/APAC expansion provides a blueprint for harmonized GTM and partner alignment.
As an advisor or board member, I bring a pattern-recognition lens on what it takes to build a repeatable go-to-market engine: clear segmentation and positioning, disciplined pipeline management, effective channel and OEM partnerships, and data-driven decision making across sales and marketing. I am especially valuable when a company needs to re-architect GTM, align product and sales, or restore growth while protecting profitability and capital efficiency.
What makes me a strong advisor/board member?
Proven turnaround and restructuring capability: I have returned Interlace Health to growth after consecutive down years, revitalized Strata Health’s US performance, and driven 40%+ growth in prior turnaround roles.
Deep GTM and channel expertise in health tech: I have launched and scaled cloud platforms, built indirect and OEM channels (e.g., Meditech, IBM, Canon), and secured industry-defining partnerships with major EHR and health IT players like Cerner, Allscripts, GE, and McKesson.
Large- and mid-market perspective: I have managed a $250M+ revenue business with a 150-person team at Nuance while also building ARR from zero to multi-million levels in early-stage ventures such as NoteSwift.
Governance, ecosystem and stakeholder savvy: My leadership in CHIME, HIMSS, and MEDITECH’s user community, plus your experience in large capital campaigns, demonstrates comfort with stakeholder management, governance-style decision making, and healthcare policy and provider dynamics.
Companies that benefit most from your expertise
The companies that will get the most leverage from me are:
Growth-stage health tech and SaaS companies (roughly $5M–$75M ARR) selling into health systems, physician groups, payers, or post-acute that need to clarify GTM, strengthen pipeline, and professionalize sales/marketing operations.
Turnaround or stalled-growth HCIT firms that have solid products and customers but inconsistent execution, where your experience returning businesses to growth and restructuring commercial functions can materially shift the trajectory.
Product-led or founder-led startups entering enterprise healthcare for the first time, where they need guidance on enterprise sales motion, partner strategy, and navigating complex players like EHR vendors, IDNs, and channel partners.
Companies integrating acquisitions or expanding internationally, where your history integrating four sales organizations at Nuance and leading UK/APAC expansion provides a blueprint for harmonized GTM and partner alignment.
Art Nicholas is an advisor and board member based in United States, specialising in Computer Software. They speak English. They are open to advisory board and board director opportunities and are available for introductions through Boardio.
Boardio matches companies with experienced advisors and board members across 120 countries — this is one of 12k+ profiles in the network.
Looking for advisors?
Browse now
Interested in becoming an advisor?
See opportunities
